Fagron NV (OTCMKTS:ARSUF – Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totaling 36,918 shares, a growth of 52.3% from the August 31st total of 24,234 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
Fagron Stock Performance
Shares of ARSUF opened at $27.50 on Thursday. Fagron has a 52-week low of $27.00 and a 52-week high of $27.90. The business’s fifty day moving average is $27.44 and its 200-day moving average is $26.88.
Fagron Company Profile
Fagron N.V. is a global pharmaceutical company focused on pharmaceutical compounding, the preparation of customized medicines for patients whose needs are not fully met by commercially available products. The company supplies pharmacies, hospitals, clinics and other healthcare professionals with products, services and expertise used to formulate individualized medications.
Its offerings include pharmaceutical raw materials, compounded medication products, formulation support, equipment and packaging, as well as technical and educational services.
Further Reading
- Five stocks we like better than Fagron
- Anthropic’s IPO Could Put Amazon’s and Alphabet’s Paper Profits to the Test
- Microsoft’s AI Spending Didn’t Change—Wall Street’s View of It Did
- Cleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach
- L3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
